You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Ezetimibe; simvastatin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Recent Clinical Trials for ezetimibe; simvastatin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Hong KongPhase 4
Cairo UniversityN/A
Aswan Heart CentreN/A

See all ezetimibe; simvastatin clinical trials

Paragraph IV (Patent) Challenges for EZETIMIBE; SIMVASTATIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VYTORIN Tablets ezetimibe; simvastatin 10 mg/10 mg 10 mg/20 mg 10 mg/40 mg 10 mg/80 mg 021687 1 2009-07-27

US Patents and Regulatory Information for ezetimibe; simvastatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 202968-004 Apr 26, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ani Pharms EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 201890-002 Apr 26, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ani Pharms EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 201890-001 Apr 26, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 208699-001 Jun 27, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal Pharms Co EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 208831-004 Nov 21, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ezetimibe; simvastatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon VYTORIN ezetimibe; simvastatin TABLET;ORAL 021687-002 Jul 23, 2004 ⤷  Try a Trial ⤷  Try a Trial
Organon VYTORIN ezetimibe; simvastatin TABLET;ORAL 021687-001 Jul 23, 2004 ⤷  Try a Trial ⤷  Try a Trial
Organon VYTORIN ezetimibe; simvastatin TABLET;ORAL 021687-004 Jul 23, 2004 ⤷  Try a Trial ⤷  Try a Trial
Organon VYTORIN ezetimibe; simvastatin TABLET;ORAL 021687-002 Jul 23, 2004 ⤷  Try a Trial ⤷  Try a Trial
Organon VYTORIN ezetimibe; simvastatin TABLET;ORAL 021687-004 Jul 23, 2004 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.